life sciences

LabCorp Loses $317M as Test Demand Slumps
Financial Performance

LabCorp Loses $317M as Test Demand Slumps

“During the first quarter, both diagnostics and drug development began experiencing the impact of the global pandemic," CEO Adam Schecter says.
By Matthew Heller | April 30, 2020
Read More
After 21 Years and a Spinoff, Profitability Finally Arrives
Strategy

After 21 Years and a Spinoff, Profitability Finally Arrives

Ironwood Pharmaceuticals is in the black for the first time thanks to its complex spinoff of pre-commercial drug development programs.
By David McCann | September 24, 2019
Read More
Biotech Firms Need a Plan B for Hiring CFOs
Recruiting

Biotech Firms Need a Plan B for Hiring CFOs

There are so many companies in the biotech sector now, their chances of finding a finance chief with the preferred profile are low.
By David McCann | April 26, 2019
Read More
GE Stock Surges on News of Biopharma Sale
Turnarounds

GE Stock Surges on News of Biopharma Sale

The $21 billion sale to Danaher is a "pivotal milestone" in GE's plan to reduce debt and strengthen its balance sheet, CEO Larry Culp says.
By Matthew Heller | February 25, 2019
Read More
Silicon Valley Bank Buys Leerink for $280M
M&A

Silicon Valley Bank Buys Leerink for $280M

The acquisition will enable to SVB to expand its investment banking services for life sciences companies.
By Matthew Heller | November 14, 2018
Read More
Interim CFO Firm Succeeds by Keeping Sights Narrow
People

Interim CFO Firm Succeeds by Keeping Sights Narrow

Veteran life-sciences CFOs leverage their specialized expertise to run their own outsourced finance services business.
By David McCann | December 8, 2017
Read More
Bayer Names Outsider Wolfgang Nickl as CFO
People

Bayer Names Outsider Wolfgang Nickl as CFO

The German company is turning to an executive with U.S. corporate experience as it moves forward with its acquisition of Monsanto.
By Matthew Heller | September 13, 2017
Read More
Thermo Fisher Makes Electron Microscopy Move
Technology

Thermo Fisher Makes Electron Microscopy Move

The lab equipment firm's $4.2 billion purchase of FEI gives it access to technology used by biopharma companies to develop drugs.
By Matthew Heller | May 30, 2016
Read More
Biotech Investor Accused of Stealing $18M
Risk & Compliance

Biotech Investor Accused of Stealing $18M

A controller and chief legal officer also played 'integral roles' in the scheme, says the SEC.
By Matthew Heller | March 31, 2016
Read More
The Other Successful Tech IPO: Veeva Systems
Technology

The Other Successful Tech IPO: Veeva Systems

All eyes are on Twitter, but cloud vendor Veeva Systems has something Twitter doesn't: real profits and a sharply defined source of future growth.
By Alissa Ponchione | November 12, 2013
Read More